Category: Health Care Costs

Cover story: Rising drug prices

With a full pipeline of new specialty drugs and ever-rising prices, the drug price problem has grown into a cover story at the Washington Examiner. Continue reading

Posted in: Cost Alert, Health Care Costs

Defensive medicine’s threat to affordable health care

Reminding us that legal threats still present an obstacle to affordability in health care, a new study in JAMA Internal Medicine finds that almost a third of the orders at one Massachusetts health system were defensive to some degree. Of the 4,215 tests and procedures ordered, $226 per patient was spent on unnecessary care, due in part to liability fears. Continue reading

Posted in: Health Care Costs

The march to value-based care

One way to bring – and keep – rising costs under control is to change the way we pay for care, BenefitsPro reports. The article describes the debate surrounding value-based care, concluding that efforts to reward providers for keeping people healthy will be a long-lasting movement. Continue reading

Posted in: Health Care Costs

What really happens when hospitals consolidate

Provider consolidation is a continuing source of debate in health care. But the facts are clear: Hospital mergers can drive up health care costs for consumers. Continue reading

Posted in: Health Care Costs, Issue Alert

Big hospital systems mean higher prices

With news of Advocate Health Care and NorthShore University HealthSystem forming the largest system in Illinois, it’s time to revisit the serious consequences of anticompetitive hospital consolidation: Research shows bigger hospital systems can lead to higher prices, not necessarily better health care. Continue reading

Posted in: Health Care Costs, Issue Alert

The drug price tipping point

“Something has to give.” That something should be drugmakers setting sustainable prescription drug prices so consumers can get the drugs they need at an affordable price. Continue reading

Posted in: Health Care Costs

Why Drug Prices Never Come Down in One Quote

Here is a Gilead executive attempting to justify the astronomical price of its hepatitis C treatment Sovaldi to Bloomberg: “We didn’t base it on our R&D costs, and we didn’t base it on our acquisition costs. The most basic answer we give is the regimen cost was the same as the old regimen cost.” Continue reading

Posted in: Health Care Costs, Issue Alert

From the feds: High-priced treatments to drive up health care spending

A new report from the Centers for Medicare and Medicaid Services published in Health Affairs shows that prescription drug spending will hold on to its role as a primary health care cost driver. Continue reading

Posted in: Health Care Costs

Don’t ignore the true health care cost drivers

With the prices for four common surgical procedures growing by double digits, a new article from NBC News reveals an urgent need to put greater focus on this dynamic that is powering health care cost growth. Continue reading

Posted in: Health Care Costs

Politico: Exposing Medicare misalignment

A new article from Politico Magazine calls more attention to misaligned incentives plaguing the health care system and driving up costs. Continue reading

Posted in: Health Care Costs